Saudi life expectancy climbed nearly six years since 2016, the health ministry says
Coverage access rose from 86% to 96.4% of the population in four years. The government's own target — 80 years by 2030 — is now less than a year of progress away.
Average life expectancy in Saudi Arabia has risen to 79.7 years, according to the Saudi health ministry — up from 74 years in 2016, when the country launched its Vision 2030 economic and social reform program, and within striking distance of the government's own stated target of 80 years by 2030 [s1].
The trajectory, not just the headline number
The ministry's reporting shows the increase wasn't a single jump but a sustained climb: 77.6 years in 2022, 78.8 years in 2023, and 79.7 years in 2024 [s1]. A nearly six-year gain in life expectancy over roughly eight years is a large move for a national population-level statistic, where changes of even a year or two typically take a decade or more to show up — which is part of why the Saudi health ministry is presenting this as evidence its broader reform program is working, rather than as background demographic drift.
What the ministry says is actually driving it
The government's own explanation centers on a shift from treatment toward prevention: expanded chronic-disease management, earlier screening for diabetes, obesity, and cancer specifically, and regulatory changes to food products — including reducing hydrogenated oils and excessive salt content [s1]. That combination — screening plus upstream food policy — is a different mechanism than, say, a specific new expensive treatment becoming available, and it's consistent with the kind of population-wide life-expectancy gains that tend to come from reducing chronic disease burden broadly rather than from any single medical breakthrough.
The access numbers behind the outcome numbers
Access to healthcare coverage rose from 86% to 96.4% of the population between 2019 and 2023, and primary healthcare coverage reached 97.5% of population clusters nationally, including remote areas [s1]. Coverage expansion on this scale — reaching population clusters in remote areas specifically — is the kind of change that plausibly explains outcome gains showing up relatively quickly: getting more people access to primary and preventive care sooner in their disease course, rather than only after a condition has progressed, is a well-established lever for improving population health statistics within a period as short as five to eight years.
What a government-reported statistic like this can't fully settle
This data comes from the Saudi health ministry itself, reporting on the outcomes of its own reform program — it isn't independently audited by an outside body in what's publicly available here, and the ministry's own causal narrative (prevention focus, screening, food policy) is its interpretation of what drove the number, not something this reporting independently verifies against alternative explanations. Broader regional trends, general economic development, or demographic shifts unrelated to the health reforms could also be contributing factors the ministry's framing doesn't isolate.
What to watch next
Whether the trajectory continues cleanly toward the 80-year target by 2030, or whether the rate of gain slows as Saudi Arabia's low-hanging preventive-care gains get exhausted and further progress requires addressing harder, more entrenched chronic disease drivers — a common pattern in countries that have already captured the fastest, most accessible wins in a health-reform push.
Sources
- Health Reforms Drive Significant Growth in Saudi Arabia's Average Lifespan — Saudi Press Agency (SPA) , April 7, 2026
Meningococcal cases tracked Umrah as pilgrim vaccination compliance fell to 54%
WHO recorded serogroup W135 disease in pilgrims returning from Saudi Arabia in early 2025. A modelling study estimates high vaccination coverage would cut expected cases by more than 80%.
Saudi Arabia reports serious road crashes down 46% over a decade
A review by the country's Public Health Authority credits enforcement and awareness campaigns for falls in crashes, deaths and injuries from 2013 to 2023 — while naming what still holds the Vision 2030 target back.
Israel had 2.5 billion shekels worth of drugs worth funding and 650 million to spend
The committee that decides what Israel's national insurance covers added new cancer and depression drugs to the 2026 list — and turned down an early Alzheimer's treatment because of what it would have cost.
MERS left the Middle East for the first time since 2019 — twice, in one week in France
Nineteen MERS cases were reported worldwide in 2025, seventeen of them in Saudi Arabia. The two in France are the first infections detected outside the region in six years.